The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Postpartum depression affects many new mothers, increasing suicide risk. New research shows preventive cognitive behavioral ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to study findings.

Men experience and express depression differently, often coping through unhealthy behaviors and resisting treatment due to ...